bioRxivImmunology
Modelling the interplay between the CD4+/CD8+ T-cell ratio and the expression of MHC-I in tumours
Abstract
Describing the anti-tumour immune response as a series of cellular kinetic reactions from known immunological mechanisms, we create a mathematical model that shows the CD4+/CD8+ T-cell ratio, T-cell infiltration and the expression of MHC-I to be interacting factors in tumour elimination. Methods from dynamical systems theory and non-equilibrium statistical mechanics are used to model the T-cell dependent anti-tumour immune response. Our model predicts a critical level of MHC-I expression which determines whether or not the tumour escapes the immune response. This critical level of MHC-I depends on the helper/cytotoxic T-cell ratio. However, our model also suggests that the immune system is robust against small changes in this ratio. We also find that T-cell infiltration and the specificity of the intra-tumour TCR repertoire will affect the critical MHC-I expression. Our work suggests that the functional form of the time evolution of MHC-I expression may explain the qualitative behaviour of tumour growth seen in patients.Mathematics Subject Classification (2010) MSC 37C25 · MSC 82C99 · MSC 37N25 · MSC 92B99Competing Interest StatementThe authors have declared no competing interest.View Full Text
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The expression of class II major histocompatibility molecules on breast tumors delays T cell exhaustion, expands the T cell repertoire and slows tumor growth
T. McCaw, M. Li, … T. Randall·bioRxiv·Apr 3, 2018
- Mathematical Model Predicts Tumor Control Patterns Induced by Fast and Slow CTL Killing Mechanisms
Y. Wang, D. Bergman, … T. L. Jackson·bioRxiv·Jul 19, 2023
- Integrating Mathematical and Mouse Models Identifies T regulatory Cell Influx as a Key Determinant of Acquired Resistance to PD-1 Immunotherapy
Rachel S Sousa, Shannon N Geels, … Francesco Marangoni·Cancer ResearchPeer-reviewed·Aug 20, 2026
- Immune-cell depleted diffuse large B-cell lymphomas have reduced expression of MHC class I
Kanutte Huse, Yngvild Nuvin Blaker, … June H. Myklebust·bioRxiv·Sep 3, 2026
- MHC-I downregulation is associated with immune-evasion in breast cancers with heterogeneous activation of epithelial-mesenchymal plasticity
Kimaya M. Bakhle, Andreas Stephanou, … Anushka Dongre·bioRxiv·Oct 19, 2026
- Intratumoral cDC1-T Cell Clusters Serve as Sites of Local Costimulation to Enhance CTL-Mediated Tumor Rejection
Catherine B. Carbone, Markus K. Brown, … Christine Moussion·bioRxiv·May 19, 2025